China has authorized Liuzon Pharmaceutical Group’s COVID-19 vaccine for emergency use, native media reported on Saturday. In keeping with Caixin International’s web site, Livzon’s protein-based vaccine is the eighth regionally produced vaccine for use as a booster shot within the nation the place about 90% of the inhabitants has acquired its main vaccine.